{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:09:10Z","timestamp":1779358150009,"version":"3.51.4"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1097\/md.0000000000005975","type":"journal-article","created":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T23:17:34Z","timestamp":1485386254000},"page":"e5975","source":"Crossref","is-referenced-by-count":6,"title":["Reactive oxygen species modulator 1 (Romo1) as a novel diagnostic marker for lung cancer-related malignant effusion"],"prefix":"10.1097","volume":"96","author":[{"given":"Seung Hyeun","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung Jae","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue In","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Joo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Yeub","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang Ho","family":"In","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-38-20210226","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1097\/JTO.0b013e318267223a","article-title":"Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer","volume":"7","author":"Morgensztern","year":"2012","journal-title":"J Thorac Oncol"},{"key":"R2-38-20210226","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/resp.12496","article-title":"Clinical features and survival of lung cancer patients with pleural effusions","volume":"20","author":"Porcel","year":"2015","journal-title":"Respirology"},{"key":"R3-38-20210226","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1378\/chest.08-2968","article-title":"Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data","volume":"136","author":"William","year":"2009","journal-title":"Chest"},{"key":"R4-38-20210226","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/thx.34.1.106","article-title":"Pleural effusion: laboratory tests in 300 cases","volume":"34","author":"Hirsch","year":"1979","journal-title":"Thorax"},{"key":"R5-38-20210226","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2217\/fon.11.45","article-title":"Diagnostic molecular biomarkers for malignant pleural effusions","volume":"7","author":"Sriram","year":"2011","journal-title":"Future Oncol"},{"key":"R6-38-20210226","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1440-1843.2007.01154.x","article-title":"Diagnosis and management of malignant pleural effusions","volume":"13","author":"Heffner","year":"2008","journal-title":"Respirology"},{"key":"R7-38-20210226","first-page":"1021","article-title":"Pleural involvement in lung cancer","volume":"7","author":"Agalioti","year":"2015","journal-title":"J Thorac Dis"},{"key":"R8-38-20210226","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1378\/chest.128.4.2298","article-title":"Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer","volume":"128","author":"Lee","year":"2005","journal-title":"Chest"},{"key":"R9-38-20210226","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1378\/chest.126.6.1757","article-title":"Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions","volume":"126","author":"Porcel","year":"2004","journal-title":"Chest"},{"key":"R10-38-20210226","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/jcla.20208","article-title":"Diagnostic utility of pleural fluid carcinoembryonic antigen and CYFRA 21-1 in patients with pleural effusion: a systematic review and meta-analysis","volume":"21","author":"Gu","year":"2007","journal-title":"J Clin Lab Anal"},{"key":"R11-38-20210226","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.bbrc.2006.06.140","article-title":"A novel protein, Romo1, induces ROS production in the mitochondria","volume":"347","author":"Chung","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"R12-38-20210226","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.bbrc.2008.02.098","article-title":"A critical role for Romo1-derived ROS in cell proliferation","volume":"369","author":"Na","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"R13-38-20210226","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bbrc.2007.05.088","article-title":"Drug resistance to 5-FU linked to reactive oxygen species modulator 1","volume":"359","author":"Hwang","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"R14-38-20210226","doi-asserted-by":"crossref","first-page":"1084.e7","DOI":"10.1053\/j.gastro.2012.06.038","article-title":"Overexpression of Romo1 promotes production of reactive oxygen species and invasiveness of hepatic tumor cells","volume":"143","author":"Chung","year":"2012","journal-title":"Gastroenterology"},{"key":"R15-38-20210226","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.lungcan.2014.05.023","article-title":"Serum reactive oxygen species modulator 1 (Romo1) as a potential diagnostic biomarker for non-small cell lung cancer","volume":"85","author":"Lee","year":"2014","journal-title":"Lung Cancer"},{"key":"R16-38-20210226","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.lungcan.2014.11.004","article-title":"Reactive oxygen species modulator 1 (Romo1) overexpression is an independent predictor of poor survival in NSCLC patients who undergo surgical resection","volume":"87","author":"Lee","year":"2015","journal-title":"Lung Cancer"},{"key":"R17-38-20210226","first-page":"47","article-title":"Prognostic value of pleural effusion in patients with non-small cell lung cancer","volume":"3","author":"Sugiura","year":"1997","journal-title":"Clin Cancer Res"},{"key":"R18-38-20210226","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1488::AID-CNCR15>3.0.CO;2-Y","article-title":"Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions","volume":"86","author":"Ferrer","year":"1999","journal-title":"Cancer"},{"key":"R19-38-20210226","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/jjco\/29.9.421","article-title":"Evaluation of cytokeratin 19 fragment (CYFRA 21-1) as a tumor marker in malignant pleural effusion","volume":"29","author":"Lai","year":"1999","journal-title":"Jpn J Clin Oncol"},{"key":"R20-38-20210226","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0169-5002(00)00153-7","article-title":"Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions","volume":"31","author":"Alatas","year":"2001","journal-title":"Lung Cancer"},{"key":"R21-38-20210226","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4143\/crt.2016.133","article-title":"Reactive oxygen species modulator 1 (Romo1) predicts poor outcomes in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy","volume":"49","author":"Lee","year":"2017","journal-title":"Cancer Res Treat"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000005975","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T02:19:09Z","timestamp":1719022749000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201701270-00038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000005975","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}